Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A magnetic resonance imaging study to assess the short-term physical modifications of the disease process after SB-061 treatment

X
Trial Profile

A magnetic resonance imaging study to assess the short-term physical modifications of the disease process after SB-061 treatment

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 26 Apr 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SB 061 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms MODIFY-MRI
  • Most Recent Events

    • 25 Apr 2019 According to a Symic Bio media release, the latest financing will be utilized to advance Symic Bios disease-modifying osteoarthritis drug, SB-061, into this global phase 2b trial which is expected to be started in the latter half of 2019.
    • 27 Aug 2017 New trial record
    • 23 Aug 2017 According to a SYMIC Biomedical media release, the company expects to report top-line results from the study in early 2018.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top